Yale Cancer Center/Smilow Cancer Hospital | Strategic Alliance Partners

Pharmacists also help patients manage their adverse effects and treat patients to live healthy lives.

Pharmacists can personalize supportive care, educate patients and their caregivers, advocate for patients, and collaborate with other health care workers.

Because of CRS and neurologic toxicity risk, the therapy is available through a REMS program.

Both indications for the CTLA-4 inhibitor were approved by the FDA in 2022.

The agent is representative of a new class of drug, ImmTAC.

With so many approved regimens and common use of oral agents in the treatment of multiple myeloma, oncology pharmacists are essential team members.

Andrea Silber, MD, said the COVID-19 pandemic has exacerbated disparities that already existed within oncology care, and she said the effects of these disparities on patients are very real and direct.

Pharmacy Times®, the leading multimedia resource for pharmacy professionals, is excited to announce Yale Cancer Center is now part of its Strategic Alliance Partnership program.